Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Alcohol Drinking 11Pancreatic Neoplasms 7Neoplasms 5Smoking Cessation 4Pancreatic Cyst 4Cancer Pain 4Agnosia 4Smoking 3Pain 3Depression 3Prostatic Neoplasms 2Postoperative Complications 2Neoplasms, Cystic, Mucinous, and Serous 2Multiple Endocrine Neoplasia Type 1 2Lymphoma, Follicular 2Lymphoma 2Leukemia 2Infections 2Head and Neck Neoplasms 2Gliosarcoma 2Glioblastoma 2Condylomata Acuminata 2Colorectal Neoplasms 2Central Nervous System Neoplasms 2Cardiovascular Diseases 2Breast Neoplasms 2Brain Neoplasms 2Alcoholism 2Wounds and Injuries 1Warts 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 130Nivolumab 87atezolizumab 80pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Ethanol × Clear all
NCT04553458 2020-09-17

Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma

Sohag University

Completed
407 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡